GKSL · Health Care · 2026-08-07

Gujarat Kidney and Super Speciality Ltd

MARKET: BULL TOPPING · 2026-08-07

₹134.4

+0.32% today

₹1,059 Cr · Small cap

About this companyHealth Care· Hospitals & Diagnostic Centres

Expand ▾

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super Speciality Limited was founded in 2014 and is headquartered in Vadodara, India.

Visit company website →

P/E (TTM)

62.7

Forward —

Earnings Growth (YoY)

+0.0%

Revenue +97.2%

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 31

1w13w26w

Week 31 — mature, watch for distribution

How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

0.45x

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

→

MA20 flat · -0.1% vs MA50 -1.9%

Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.

Sector

Health Care

↑ Building

Stage 2%

51.6%

20d Δ

+1.6pp

1M return

+3.1%

3M return

+11.6%

Sector Stage-2 % · last 20 days

Sector has 79 Stage 2 leaders. See Health Care Stage 2 →

Industry

Hospitals & Diagnostic Centres

↑ Building

Stage 2%

59.3%

20d Δ

+7.4pp

1M return

+1.2%

3M return

+9.0%

Industry Stage-2 % · last 20 days

Industry has 16 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →

Price + Volume Chart

Loading price chart…

Stage Cycle Timeline2025-12-30 → 2026-08-07

S? 32w

2025-12-302026-08-07

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 32w current

Total tracked: 32 weeks across 1 stage run.

+2.6%

-4.0%

+28.9%

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-08-07S—

Wk 31 · Vol —x

2026-08-06S—

Wk 31 · Vol —x

2026-08-05S—

Wk 31 · Vol —x

2026-08-04S—

Wk 30 · Vol —x

2026-08-03S—

Wk 30 · Vol —x

2026-07-31S—

Wk 30 · Vol —x

2026-07-30S—

Wk 30 · Vol —x

2026-07-29S—

Wk 30 · Vol —x

2026-07-28S—

Wk 29 · Vol —x

2026-07-27S—

Wk 29 · Vol —x

2026-07-24S—

Wk 29 · Vol —x

2026-07-23S—

Wk 29 · Vol —x

Sector Peers — Stage 2All →

DIVISLAB

wk 12 · -3.6% from hi

8.5

LAURUSLABS

wk 16 · -0.3% from hi

8.4

PPLPHARMA

wk 4 · 0.0% from hi

8.2

LALPATHLAB

wk 9 · 0.0% from hi

7.9

SHILPAMED

wk 13 · 0.0% from hi

7.8

Moving averages & range

50 DMA

₹129.8

200 DMA

—

52W High

—

52W Low

—

5D Low

₹127.7

Resistance levels (recent highs)

20d High

₹134.6

60d High

₹143.3

120d High

₹143.3

250d High

—

Next resistance

+0.1%

to 20d High

All analytics based on EOD data. Data as of 2026-08-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.